Friday, February 27, 2009
The ethics and safety behind the global outsourcing of clinical trials is once again being debated, with the release of a new study reporting that U.S. drug developers conduct most of their late-stage drug trials outside of the United States.
CenterWatch, a global source for clinical trials information, will present results from four surveys aimed at examining the quality of relationships between sponsors and investigative sites from around the world at ExL Pharma’s 4th Investigator Relationship Management conference to be held Feb. 23-24, 2009, in Baltimore, Md.
Contract research organization (CRO) WIL Research Laboratories and its parent company WIL Research Holding Company have acquired Midwest BioResearch, a company that provides drug disposition and toxicology services to drug developers. Neither company provided financial details of the deal.
Clinical Trials and Surveys Corp (C-TASC), a clinical trials solutions company, hired three new biostatisticians and plans to double its staff in the next year. The company, which currently employs 35 people, plans to increase to 60 employees by February 2010 in order to keep up with increased demand for its clinical trial services and technologies.